MMP-2 and TIMP-1 Are Derived from, Not in Response to, Pancreatic Cancer

By Bloomston M.   Shafii A.   Zervos E.E.   Rojiani A.   Rosemurgy A.S.  

Journal of Surgical Research, Vol. 102, Iss. 1, 2002-01 ,pp. : 35-38

Academic Press

Access to resources Recommend Favorite

Role of Urokinase Plasminogen Activator Receptor in Thrombospondin 1-Mediated Tumor Cell Invasion

By Albo D.   Berger D.H.   Rothman V.L.   Tuszynski G.P.  

Journal of Surgical Research, Vol. 82, Iss. 2, 1999-04 ,pp. : 331-338

Academic Press

Access to resources Recommend Favorite

Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma

By Ferrari Cristina  

Acta Orthopaedica Scandinavica, Vol. 75, Iss. 4, 2004-08 ,pp. : 487-491

Informa Healthcare

Access to resources Recommend Favorite

Abnormal Levels of Urokinase Plasminogen Activator Protein and Tissue Plasminogen Activator Activity in Human Aortic Aneurysms

By Falkenberg Mårten   Holmdahl Lena   Tjärnström Johan   Risberg Bo  

European Journal of Surgery, Vol. 167, Iss. 1, 2001-01 ,pp. : 10-14

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Low-Dose Erythropoiesis-Stimulating Agents on Peritoneal Fibrosis Induced by Chemical Peritonitis and on Peritoneal Tissue MMP-2 and TIMP-2 Levels in Rats

By Yildirim Ayse   Ozkan Orhan Veli   Aslan Ahmet   Koseoglu Zikret   Borazan Ali  

Renal Failure, Vol. 31, Iss. 7, 2009-08 ,pp. : 567-572

Informa Healthcare

Access to resources Recommend Favorite